This startup will leverage AI to analyze data from exceptional cancer survivors, identifying unique biological markers, lifestyle factors, and treatment responses that contributed to their resilience. The platform will then use these insights to develop personalized risk assessment tools and preventative strategies for individuals at high risk of cancer or those undergoing treatment, moving beyond population averages to focus on individual resilience factors.